1. Home
  2. KALA vs DUOT Comparison

KALA vs DUOT Comparison

Compare KALA & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$2.25

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$13.43

Market Cap

244.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
DUOT
Founded
2009
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
244.3M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
KALA
DUOT
Price
$2.25
$13.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$31.50
$17.00
AVG Volume (30 Days)
1.2M
782.9K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
67.39
53.96
EPS
N/A
N/A
Revenue
N/A
$27,023,651.00
Revenue This Year
N/A
$50.98
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
271.16
52 Week Low
$0.07
$5.78
52 Week High
$20.58
$15.28

Technical Indicators

Market Signals
Indicator
KALA
DUOT
Relative Strength Index (RSI) 59.31 67.84
Support Level $0.32 $8.12
Resistance Level $3.96 N/A
Average True Range (ATR) 0.37 1.13
MACD -0.07 0.55
Stochastic Oscillator 7.27 73.45

Price Performance

Historical Comparison
KALA
DUOT

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.

Share on Social Networks: